Drugbank Logo

Search Results

Search for "Didanosine" returned 8 results

Showing 1-8 out of 8
DrugBank ID Name Formula Weight
DB00900
DrugCard button for DB00900
Didanosine C10H12N4O3 236.2273
... increases the effect and toxicity of didanosine Tipranavir Didanosine EC levels may be reduced Valganciclovir The antiviral agent increases the effect and toxicity of didanosine Zalcitabine ...
DB02392
DrugCard button for DB02392
2'3'-Dideoxyinosine C10H12N4O3 236.2273
Didanosine is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase; ddI is then metabolized to dideoxyadenosine triphosphate, its ...
DB00300
DrugCard button for DB00300
Tenofovir C9H14N5O4P 287.2123
Monitor for changes in virologic response and Didanosine toxicity during concomitant therapy. [(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid D01982 Tenofovir inhibits the activity ...
DB01004
DrugCard button for DB01004
Ganciclovir C9H13N5O4 255.2306
... The antiviral agent increases the effect and toxicity of didanosine Probenecid Probenecid increases the effect and toxicity of ganciclovir/valganciclovir Zidovudine Hematotoxicity Take with ...
DB00685
DrugCard button for DB00685
Trovafloxacin C20H15F3N4O3 416.3533
The Didanosine formulation contains magnesium and aluminum ions that intefere with Trovafloxacin absorption. Administer Trovafloxacin 2 hours before or 6 hours after the Didanosine dose to ...
DB01610
DrugCard button for DB01610
Valganciclovir C14H22N6O5 354.3617
(Note: Valganciclovir is converted to Ganciclovir in vivo) Didanosine The adverse/toxic effects of Didanosine, a reverse transcriptase inhibitor (nucleoside), may be enhanced by Valganciclovir ...
DB00684
DrugCard button for DB00684
Tobramycin C18H37N5O9 467.5145
... of nephrotoxicity Cyclosporine Increased risk of nephrotoxicity Didanosine Increased risk of nephrotoxicity Doxacurium The agent increases the effect of the muscle relaxant Enalapril Increased ...
DB00932
DrugCard button for DB00932
Tipranavir C31H33F3N2O5S 602.6640
Didanosine Tipranavir decreases the concentration of Didanosine. Diethylstilbestrol Diethylstilbestrol may increase the adverse dermatological effects (i.e. skin rash) of Tipranavir. Tipranavir ...
Showing 1-8 out of 8

This project is supported by Genome Alberta & Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $600 million in funding from the federal government. This project is also supported in part by GenomeQuest, Inc., an enterprise genomic information company serving the life science community.